Redigerer MVC COVID-19-vaksine

'''MVC COVID-19-vaksine''' ([[kinesisk]]: 高端新冠肺炎疫苗; eller '''MVC-COV1901'''), også kjent som '''Medigen''', er en [[covid-19-vaksine]] utviklet av Medigen Vaccine Biologics i [[Taiwan]] og Dynavax Technologies.<ref>{{cite news |title=Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate |url=https://www.globenewswire.com/news-release/2020/07/23/2066551/0/en/Dynavax-and-Medigen-Announce-Collaboration-to-Develop-a-Novel-Adjuvanted-COVID-19-Vaccine-Candidate.html |access-date=7. juni 2021 |publisher=GlobeNewswire |date=23. juli 2020}}</ref><ref>{{cite web |title=A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19) |url=https://clinicaltrials.gov/ct2/show/NCT04695652 |website=clinicaltrials.gov |publisher=United States National Library of Medicine |access-date=11. mars 2021 |url-status=live}}</ref><ref>{{cite web |title=A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 |url=https://clinicaltrials.gov/ct2/show/NCT04487210 |website=clinicaltrials.gov |publisher=United States National Library of Medicine |access-date=11. mars 2021 |url-status=live}}</ref><ref>{{cite journal |title=A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults |url=https://clinicaltrials.gov/ct2/show/NCT04822025 |website=clinicaltrials.gov |date=28. mars 2021 |publisher=United States National Library of Medicine |access-date=3. april 2021 |url-status=live}}</ref><ref>{{cite news|url=https://www.mirrormedia.mg/story/20210610inv003/|title=【獨家】【國產疫苗解盲1】高端實體疫苗針劑首曝光 「每天9萬劑」生產基地直擊|author=黃驛淵|agency=Mirror Media|date=2021-06-10|lang=zh-tw}}</ref>

Denne [[vaksine]]n er laget på grunnlag av et rekombinant S-2P-[[spikeprotein]] fra det amerikanske [[National Institutes of Health]].<ref>{{cite news|url=https://geneonline.news/en/medigen-signs-agreement-with-metronic-making-it-the-first-taiwan-made-vaccine-deal/|title=Medigen Signs Agreement with Metronic, Making it the First Taiwan-made Vaccine Deal|first=Tyler|last=Chen|agency=GeneOnline|date=2020-11-26}}</ref>

Den 19. juli 2021 fikk MVC COVID-19-vaksinen nødtillatelse (''Emergency Use Authorization'' - EUA) fra Republikken Kinas regjering.<ref>{{Cite web|title=MVC COVID-19 Vaccine Obtains Taiwan EUA Approval|url=https://www.medigenvac.com/public/en/news/detail/83?from_sort=2|access-date=2021-08-07|website=www.medigenvac.com|archive-date=2021-10-09|archive-url=https://web.archive.org/web/20211009201715/https://www.medigenvac.com/public/en/news/detail/83?from_sort=2|url-status=yes}}</ref> Dette var imidlertid til tross for at effektdata og fase-3-statistikk fortsatt manglet. Den 31. august 23 2021 mottok president [[Tsai Ing-Wen]] som en de første en dose av vaksinen.<ref>[https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/Taiwan-begins-contested-rollout-of-new-Medigen-domestic-vaccine Taiwan begins contested rollout of new Medigen domestic vaccine], ''Nikkei Asia'', Erin Hale, 23. august 2021</ref>
== Referanser ==
<references />

[[Kategori:Covid-19-vaksiner]]